A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

NCT05214677 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Rheumatoid Arthritis
Back Pain
Acute Upper Respiratory Tract Infection

Interventions

DRUG: DW1809
DRUG: DW1809-1

Sponsor

Daewon Pharmaceutical Co., Ltd.